Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis

被引：0

作者：

Kulkarni, Amit A. ^{[1
]}

Hennessy, Cassandra ^{[2
]}

Wilson, Grace ^{[1
]}

Ramesh, Vidhyalakshmi ^{[1
]}

Hwang, Clara ^{[3
]}

Awosika, Joy ^{[4
]}

Bakouny, Ziad ^{[5
]}

Khan, Hina ^{[6
]}

Vilar-Compte, Diana ^{[7
]}

McKay, Rana ^{[8
]}

Jani, Chinmay ^{[8
,9
]}

Weissmann, Lisa ^{[8
,9
]}

Griffiths, Elizabeth ^{[9
,10
]}

Batist, Gerald ^{[10
,11
]}

Bouganim, Nathaniel ^{[10
,11
]}

Mavromatis, Blanche ^{[12
]}

Bashir, Babar ^{[13
]}

Nguyen, Ryan H. ^{[14
]}

Riess, Jonathan W. ^{[15
]}

Puc, Matthew ^{[16
]}

Kasi, Anup ^{[17
]}

Berg, Stephanie ^{[18
]}

Castillo, Dan Ran ^{[19
]}

Hayes-Lattin, Brandon ^{[20
]}

Hosmer, Wylie ^{[21
]}

Flora, Daniel ^{[22
]}

Mishra, Sanjay ^{[5
,6
]}

French, Benjamin ^{[1
,2
]}

Warner, Jeremy L. ^{[5
,6
]}

Lopes, Gilberto ^{[23
]}

Peters, Solange ^{[24
]}

Florez, Narjust ^{[25
]}

机构：

[1] Univ Minnesota, Minneapolis, MN USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] Henry Ford Hlth Syst, Detroit, MI USA

[4] Univ Cincinnati, Cincinnati, OH USA

[5] Dana Farber Canc Inst, Boston, MA USA

[6] Brown Univ, Legorreta Canc Ctr, Providence, RI USA

[7] Inst Nacl Cancerol, Mexico City, Mexico

[8] Univ Calif San Diego, San Diego, CA USA

[9] Mt Auburn Hosp, Cambridge, MA USA

[10] Rosewell Pk Comprehens Canc Ctr, Buffalo, NY USA

[11] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada

[12] UPMC Western Maryland, Cumberland, MD USA

[13] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA

[14] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA

[15] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA

[16] Virtua Hlth, Marlton, NJ USA

[17] Univ Kansas, Kansas City, KS USA

[18] Loyola Univ, Chicago, IL USA

[19] Loma Linda Univ, Loma Linda, CA USA

[20] Oregon Hlth & Sci Univ, Portland, OR USA

[21] Hartford HealthCare Canc Inst, Southington, CT USA

[22] St Elizabeth Healthcare, Edgewood, KY USA

[23] Univ Miami, Miami, FL USA

[24] Ctr Hosp Univ Vaudois CHUV, Lausanne, Switzerland

[25] Dana Farber Brigham Canc Ctr, Boston, MA USA

来源：

CLINICAL LUNG CANCER | 2024年 / 25卷 / 05期

关键词：

Chemotherapy; Immunotherapy; Targeted therapy; Thoracic Cancers; LUNG-CANCER;

D O I：

10.1016/j.cllc.2024.04.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with thoracic cancers and COVID-19 have high mortality and morbidity. • Systematic data evaluating the impact of recent anti-cancer therapies on COVID-19 outcomes in patients with thoracic cancers are limited. • We analyzed clinical data from patients with thoracic cancers and COVID-19 (N=927) to systematically evaluate the impact of recent anti-cancer therapies on the clinical outcomes of COVID-19 from the COVID-19 and Cancer Consortium (CCC19). • As opposed to immunotherapy or targeted therapy, recent (<3 months prior to COVID-19 diagnosis) cytotoxic chemotherapy exposure was significantly associated with COVID-19 severity. • None of the other systemic therapies or treatment modalities were significantly associated with 30-day all-cause mortality. • Baseline steroid use of 10 mg or more of prednisone equivalent was not associated COVID-19 severity and 30-day all-cause mortality. © 2024 Elsevier Inc.

引用

下载

页码：e229 / e237.e7

页数：16

共 50 条

[31] Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center
Basse, Clemence
Daniel, Catherine
Livartowski, Alain
Beaucaire-Danel, Sophie
Girard, Nicolas
LUNG CANCER, 2021, 157 : 79 - 84
[32] Impact of COVID-19 on gynecologic oncology patients: an SGO COVID-19 and Gynecologic Cancer Registry study
Glaser, Gretchen
Lara, Olivia
Pothuri, Bhavana
Grimaldi, Carolina Gomez
Prescott, Lauren
Mastroyannis, Spyridon
Kim, Sarah
ElNaggar, Adam
Torres, Diogo
Conrad, Lesley
McGree, Michaela
Weaver, Amy
Huh, Warner
Cohn, David
Fader, Amanda
GYNECOLOGIC ONCOLOGY, 2022, 166 : S34 - S34
[33] Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients.
Dawsey, Scott J.
Pennell, Nathan A.
Lemmon, Christopher
Nizam, Amanda
Wei, Wei
Gilligan, Timothy D.
Ornstein, Moshe C.
Gupta, Shilpa
CLINICAL CANCER RESEARCH, 2020, 27 (06)
[34] COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
Borno, Hala T.
Kim, Mi-Ok
Hong, Julian C.
Yousefi, Sasha
Lin, Amy
Tolstykh, Irina
Zhang, Sylvia
McKay, Rana R.
Harismendy, Olivier
Cinar, Pelin
Rugo, Hope
Koshkin, Vadim S.
Rabow, Maya
Wang, Christine
Bailey, Adina
Small, Eric J.
ONCOLOGIST, 2022, 27 (05): : 398 - 406
[35] The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study
Castellano, Cecilia A.
Sun, Tianyi
Ravindranathan, Deepak
Hwang, Clara
Balanchivadze, Nino
Singh, Sunny R. K.
Griffiths, Elizabeth A.
Puzanov, Igor
Ruiz-Garcia, Erika
Vilar-Compte, Diana
Cardenas-Delgado, Ana I.
McKay, Rana R.
Nonato, Taylor K.
Ajmera, Archana
Yu, Peter P.
Nadkarni, Rajani
O'Connor, Timothy E.
Berg, Stephanie
Ma, Kim
Farmakiotis, Dimitrios
Vieira, Kendra
Arvanitis, Panos
Saliby, Renee M.
Labaki, Chris
El Zarif, Talal
Wise-Draper, Trisha M.
Zamulko, Olga
Li, Ningjing
Bodin, Brianne E.
Accordino, Melissa K.
Ingham, Matthew
Joshi, Monika
Polimera, Hyma V.
Fecher, Leslie A.
Friese, Christopher R.
Yoon, James J.
Mavromatis, Blanche H.
Brown, Jacqueline T.
Russell, Karen
Nanchal, Rahul
Singh, Harpreet
Tachiki, Lisa
Moria, Feras A.
Nagaraj, Gayathri
Cortez, Kimberly
Abbasi, Saqib H.
Wulff-Burchfield, Elizabeth M.
Puc, Matthew
Weissmann, Lisa B.
Bhatt, Padmanabh S.
CANCER, 2024, 130 (12) : 2191 - 2204
[36] How did the COVID-19 pandemic affect the management of patients with cancer? What is the impact of anti-cancer medications on the immune response to the COVID-19 vaccinations?.
Abdelsalam, Mahmoud
Salem, Maged
McPherson, Alexander
Abdel-Samad, Nizar
Obrien, Pierre
Ross, Laura
Sughayar, Rana
Avileli, Mrudula
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[37] Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study
Wagner, Michael J.
Hennessy, Cassandra
Beeghly, Alicia
French, Benjamin
Shah, Dimpy P.
Croessmann, Sarah
Vilar-Compte, Diana
Ruiz-Garcia, Erika
Ingham, Matthew
Schwartz, Gary K.
Painter, Corrie A.
Chugh, Rashmi
Fecher, Leslie
Park, Cathleen
Zamulko, Olga
Trent, Jonathan C.
Subbiah, Vivek
Khaki, Ali Raza
Tachiki, Lisa
Nakasone, Elizabeth S.
Loggers, Elizabeth T.
Labaki, Chris
Saliby, Renee Maria
McKay, Rana R.
Ajmera, Archana
Griffiths, Elizabeth A.
Puzanov, Igor
Tap, William D.
Hwang, Clara
Jhawar, Sachin R.
Hayes-Lattin, Brandon
Wulff-Burchfield, Elizabeth
Kasi, Anup
Reuben, Daniel Y.
Nagaraj, Gayathri
Joshi, Monika
Polimera, Hyma
Kulkarni, Amit A.
Esfahani, Khashayar
Kwon, Daniel H.
Paoluzzi, Luca
Bilen, Mehmet A.
Durbin, Eric B.
Grivas, Petros
Warner, Jeremy L.
Davis, Elizabeth J.
CANCERS, 2022, 14 (17)
[38] Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
Wang, Bolin
Huang, Yan
ONCOIMMUNOLOGY, 2020, 9 (01):
[39] Repurposing Anti-Cancer Drugs for COVID-19 Treatment
Borcherding, Nicholas
Jethava, Yogesh
Vikas, Praveen
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5045 - 5058
[40] Impact of antitumor regimens on the outcomes of cancer patients with COVID-19: a pooled analysis
Lu, Haohua
Shi, Yu
Chen, Kelie
Chen, Zhi
Zhu, Haihong
Niu, Yuequn
Xia, Dajing
Wu, Yihua
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2021, 22 (10): : 876 - 884

← 1 2 3 4 5 →